Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NIROGACESTAT vs NIRSEVIMAB-ALIP: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NIROGACESTAT vs NIRSEVIMAB-ALIP: Safety Overview

Metric NIROGACESTAT NIRSEVIMAB-ALIP
Total FAERS Reports 497 783
Deaths Reported 7 32
Death Rate 1.4% 4.1%
Hospitalizations 54 281
Average Patient Age 45.2 yrs 3.3 yrs
% Female Patients 69.6% 46.3%
Manufacturer SpringWorks Therapeutics, Inc. N/A
Route ORAL N/A
Marketing Status N/A Prescription